Regeneron Pharmaceuticals, Inc. (REGN)
770.77
-3.17
(-0.41%)
USD |
NASDAQ |
Dec 31, 10:41
Regeneron Pharmaceuticals Market Cap: 81.01B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 176.26B |
| Gilead Sciences, Inc. | 152.19B |
| Johnson & Johnson | 498.29B |
| Eli Lilly & Co. | 966.29B |
| Merck & Co., Inc. | 262.30B |
Market Cap Related Metrics
| PE Ratio | 18.45 |
| PS Ratio | 5.962 |
| PEG Ratio | 5.488 |
| Price to Book Value | 2.617 |
| Price to Free Cash Flow | 21.89 |
| Price | 770.77 |
| Earnings Yield | 5.42% |
| PEGY Ratio | 5.488 |
| Operating PE Ratio | 22.18 |
| Normalized PE Ratio | 19.21 |